NCT00101842View on ClinicalTrials.gov

Gemcitabine and Platinol Followed by Pemetrexed and Gemcitabine in Patients With Advanced or Metastatic Bladder Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2004

Study Completion Date

July 31, 2006

Conditions

Carcinoma, Transitional Cell

Interventions

DRUG

Pemetrexed

DRUG

Gemcitabine

DRUG

Platinol

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician., Dallas

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY

NCT00101842 - Gemcitabine and Platinol Followed by Pemetrexed and Gemcitabine in Patients With Advanced or Metastatic Bladder Cancer | Biotech Hunter | Biotech Hunter